Results 141 to 150 of about 43,571 (190)

2.2Å ブンカイノウ デノ ヒト ユライ モノアミン サンカ コウソA ノ ケッショウ コウゾウ ト ソノ マクカンツウ ヘリックス ノ キノウテキ ヤクワリ [PDF]

Son, Seyoung, ソン, セヨン, 孫, 世永   +2 more
core  

Correction to "The MAO-B Inhibitor Selegiline Reduces the Viability of Different Prostate Cancer Cell Lines and Enhances the Effects of Anti-Androgen and Cytostatic Agents". [PDF]

Pharmacol Res Perspect
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Monoamine oxidase inhibitor overdose

Annals of Emergency Medicine, 1984
Described is the clinical course of a 26-year-old woman who died following an overdose of the MAO inhibitor phenelzine. Signs and symptoms of toxicity were delayed in onset. Initial findings of excessive neuromuscular activity were followed by severe hyperthermia, coma, cardiovascular collapse, acute renal failure, hemolysis, rhabdomyolysis, and ...
C H, Linden, B H, Rumack, C, Strehlke
openaire   +2 more sources

Switching Monoamine Oxidase Inhibitors

Drug Intelligence & Clinical Pharmacy, 1985
Substituting one monoamine oxidase inhibitor for another is recommended only after a drug-free interval to avoid hypertensive emergencies. The evidence and mechanism firmly supporting this caution is lacking. We report a case where monoamine oxidase inhibitors were substituted without apparent adverse consequences.
B L, True, B, Alexander, B, Carter
openaire   +2 more sources

Monoamine Oxidase Inhibitors

Expert Opinion on Therapeutic Patents, 2002
Forty-nine monoamine oxidase inhibitor (MAOI)-related patents published between January 1998 and July 2002 are included in this review. They are classified and reviewed under three categories: (i) novel chemical entities, (ii) novel formulations, delivery systems and processing methods of known MAOIs and (iii) novel utilities and/or pharmaceutical ...
openaire   +2 more sources

Monoamine oxidase inhibitors

Abstract Monoamine oxidase inhibitors (MAOIs) are a separate class from other antidepressants, treating different forms of depression as well as other nervous system disorders such as panic disorder, social phobia, and depression with atypical features. They increase the availability of neurotransmitters such as norepinephrine, serotonin,
Neha Pawar, Timothy J. Wiegand
openaire   +2 more sources

Monoamine Oxidase Inhibitors

Journal of Pharmaceutical Sciences, 1972
M Z, Hussain, M, Harinath
  +7 more sources